跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BioFlo™ DuraMax with Endexo Technology Chronic Hemodialysis VascPak, Dual Valve - Catheter, haemodialysis, implantable - TGA Drug Approval Details
Approvals
/
TGA
/
BioFlo™ DuraMax with Endexo Technology Chronic Hemodialysis VascPak, Dual Valve - Catheter, haemodialysis, implantable
Approved
STANDARD
BioFlo™ DuraMax with Endexo Technology Chronic Hemodialysis VascPak, Dual Valve - Catheter, haemodialysis, implantable
Merit Medical Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a1d0df636bc4d725
Company
Merit Medical Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
a1d0df636bc4d725
Product Name
BioFlo™ DuraMax with Endexo Technology Chronic Hemodialysis VascPak, Dual Valve - Catheter, haemodialysis, implantable
Artg Id
514870
Artg Name
Merit Medical Australia Pty Ltd - BioFlo™ DuraMax with Endexo Technology Chronic Hemodialysis VascPak, Dual Valve - Catheter, haemodialysis, implantable
Sponsor
Merit Medical Australia Pty Ltd
Artg Date
2025-10-08
Registration Type
Device
Therapeutic Good Type
Medical devices
Licence Status
A
Licence Category
INC
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a1d0df636bc4d725
Type
Standard
Back to TGA Approvals
